Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DOXORUBICIN CARDIOTOXICITY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 139 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lothstein, L; Israel, M; Sweatman, TW
      Anthracycline drug targeting: cytoplasmic versus nuclear - a fork in the road

      DRUG RESISTANCE UPDATES
    2. Porea, TJ; Dreyer, ZE; Bricker, JT; Mahoney, DH
      Evaluation of left ventricular function in asymptomatic children about to undergo anthracycline-based chemotherapy for acute leukemia: An outcome study

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    3. Kramer, K; Kinter, L; Brockway, BP; Voss, HP; Remie, R; Van Zutphen, BLM
      The use of radiotelemetry in small laboratory animals: Recent advances

      CONTEMPORARY TOPICS IN LABORATORY ANIMAL SCIENCE
    4. Hershberger, RE; Ni, HY; Toy, W; Wilson, RA
      Distribution and declines in cardiac allograft radionuclide left ventricular ejection fractions in relation to late mortality

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    5. Sayed-Ahmed, MM; Salman, TM; Gaballah, HE; El-Naga, SAA; Nicolai, R; Calvani, M
      Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy

      PHARMACOLOGICAL RESEARCH
    6. Wersinger, C; Lelong-Rebel, IH; Rebel, G
      Sensitivity of taurine uptake to oxygen-derived reactive substances in MDRand non-MDR cells

      AMINO ACIDS
    7. Dazzi, H; Kaufmann, K; Follath, F
      Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia- Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity inpatients treated for acute leukaemia at theUniversity Hospital of Zurich, Switzerland, between 1990 and 1996

      ANNALS OF ONCOLOGY
    8. Sato, T; Harada, K; Tamura, M; Watanabe, A; Ishii, M; Takada, G
      Cardiorespiratory exercise capacity and its relation to a new Doppler index in children previously treated with anthracycline

      JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
    9. Mondelli, JA; Di Luzio, S; Nagaraj, A; Kane, BJ; Smulevitz, B; Nagaraj, AV; Greene, R; McPherson, DD; Rigolin, VH
      The validation of volumetric real-time 3-dimensional echocardiography for the determination of left ventricular function

      JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
    10. Meinardi, MT; van Veldhuisen, DJ; Gietema, JA; Dolsma, WV; Boomsma, F; van den Berg, MP; Volkers, C; Haaksma, J; de Vries, EGE; Sleijfer, DT; van der Graaf, WTA
      Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    11. Della Torre, P; Podesta, A; Imondi, AR; Moneta, D; Sammartini, U; Arrigoni, C; Terron, A; Brughera, M
      PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    12. Lopaczynski, W; Zeisel, SH
      Antioxidants, programmed cell death, and cancer

      NUTRITION RESEARCH
    13. Hall, KS; Wiklund, T; Erikstein, B; Holte, H; Kvalheim, G; Sommer, HH; Andersen, A; Skovlund, E; Bergh, J; Hall, C
      Effects of dose-intensive chemotherapy and radiotherapy on serum n-terminal proatrial natriuretic peptide in high-risk breast cancer patients

      BREAST CANCER RESEARCH AND TREATMENT
    14. Nousiainen, T; Vanninen, E; Jantunen, E; Remes, J; Kuikka, J; Hartikainen, J
      Anthracycline-induced cardiomyopathy: long-term effects on myocardial cellintegrity, cardiac adrenergic innervation and fatty acid uptake

      CLINICAL PHYSIOLOGY
    15. Mladosievicova, B; Foltinova, A; Petrasova, H; Bernadic, M; Hulin, I
      Signal-averaged electrocardiography in survivors of Hodgkin's disease treated with and without dexrazoxane

      NEOPLASMA
    16. Mijares, A; Lopez, JR
      L-carnitine prevents increase in diastolic [Ca2+] induced by doxorubicin in cardiac cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    17. Minotti, G; Parlani, M; Salvatorelli, E; Menna, P; Cipollone, A; Animati, F; Maggi, CA; Manzini, S
      Impairment of myocardial contractility by anticancer anthracyclines: role of secondary alcohol metabolites and evidence of reduced toxicity by a novel disaccharide analogue

      BRITISH JOURNAL OF PHARMACOLOGY
    18. Horenstein, MS; Vander Heide, RS; L'Ecuyer, TJ
      Molecular basis of anthracycline-induced cardiotoxicity and its prevention

      MOLECULAR GENETICS AND METABOLISM
    19. Prestor, VV; Rakovec, P; Kozelj, M; Jereb, B
      Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    20. Green, DM; Grigoriev, YA; Nan, B; Takashima, JR; Norkool, PA; D'Angio, GJ; Breslow, NE
      Congestive heart failure after treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group

      JOURNAL OF CLINICAL ONCOLOGY
    21. Lackner, H; Benesch, M; Schagerl, S; Kerbl, R; Schwinger, W; Urban, C
      Prospective evaluation of late effects after childhood cancer therapy witha follow-up over 9 years

      EUROPEAN JOURNAL OF PEDIATRICS
    22. Singal, P; Li, TM; Kumar, D; Danelisen, I; Iliskovic, N
      Adriamycin-induced heart failure: mechanisms and modulation

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    23. Rammeloo, LAJ; Postma, A; Sobotka-Plojhar, MA; Bink-Boelkens, MTE; van der Does-van der Berg, A; Veerman, AJP; Kamps, WA
      Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: No long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group

      MEDICAL AND PEDIATRIC ONCOLOGY
    24. Matsushita, T; Okamato, M; Toyama, J; Kodama, I; Ito, S; Fukutomi, T; Suzuki, S; Itoh, M
      Adriamycin causes dual inotropic effects through complex modulation of myocardial Ca2+ handling

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    25. Olson, RD; Li, XD; Palade, P; Shadle, SE; Mushlin, PS; Gambliel, HA; Fill, M; Boucek, RJ; Cusack, BJ
      Sarcoplasmic reticulum calcium release is stimulated and inhibited by daunorubicin and daunorubicinol

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    26. Burke, BE; Gambliel, H; Olson, RD; Baur, FK; Cusack, BJ
      Prevention by dexrazoxane of down-regulation of ryanodine receptor gene expression in anthracycline cardiomyopathy in the rat

      BRITISH JOURNAL OF PHARMACOLOGY
    27. Erselcan, T; Kairemo, KJA; Wiklund, TA; Hernberg, M; Blomqvist, CP; Tenhunen, M; Bergh, J; Joensuu, H
      Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer

      BRITISH JOURNAL OF CANCER
    28. Okumura, H; Iuchi, K; Yoshida, T; Nakamura, S; Takeshima, M; Takamatsu, H; Ikeno, A; Usuda, K; Ishikawa, T; Ohtake, S; Matsuda, T
      Brain natriuretic peptide is a predictor of anthracycline-induced cardiotoxicity

      ACTA HAEMATOLOGICA
    29. Tjeerdsma, G; Meinardi, MT; van der Graaf, WTA; van den Berg, MP; Mulder, NH; Crijns, HJGM; de Vries, EGE; van Veldhuisen, DJ
      Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables

      HEART
    30. Dell'Acqua, G; Polishchuck, R; Fallon, JT; Gordon, JW
      Cardiac resistance to adriamycin in transgenic mice expressing a rat alpha-cardiac myosin heavy chain human multiple drug resistance 1 fusion gene

      HUMAN GENE THERAPY
    31. Gennari, A; Salvadori, B; Donati, S; Bengala, C; Orlandini, C; Danesi, R; Del Tacca, M; Bruzzi, P; Conte, PF
      Cardiotoxicity of epirubicin/paclitaxel-containing regimens: Role of cardiac risk factors

      JOURNAL OF CLINICAL ONCOLOGY
    32. Bu'Lock, FA; Mott, MG; Oakhill, A; Martin, RP
      Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: A prospective study

      PEDIATRIC CARDIOLOGY
    33. Hoekman, K; van der Vijgh, WJF; Vermorken, JB
      Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer

      DRUGS
    34. Sawyer, DB; Fukazawa, R; Arstall, MA; Kelly, RA
      Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane

      CIRCULATION RESEARCH
    35. Papadopoulou, LC; Theophilidis, G; Thomopoulos, GN; Tsiftsoglou, AS
      Structural and functional impairment of mitochondria in adriamycin-inducedcardiomyopathy in mice: Suppression of cytochrome c oxidase II gene expression

      BIOCHEMICAL PHARMACOLOGY
    36. Suzuki, J; Yanagisawa, A; Shigeyama, T; Tsubota, J; Yasumura, T; Shimoyama, K; Ishikawa, K
      Early detection of anthracycline-induced cardiotoxicity by radionuclide angiocardiography

      ANGIOLOGY
    37. Kleinhans, E
      Guidelines for equilibrium radionuclide ventriculography

      NUKLEARMEDIZIN
    38. STEINHERZ LJ; WEXLER LH
      THE PREVENTION OF ANTHRACYCLINE CARDIOMYOPATHY

      Progress in pediatric cardiology
    39. HOGARTY AN; SILBER JH; PARIDON SM
      CARDIOPULMONARY EXERCISE TESTING IN EVALUATION OF THE FUNCTIONAL-CAPACITY OF SURVIVORS OF CHILDHOOD-CANCER

      Progress in pediatric cardiology
    40. Badary, OA
      Taurine attenuates Fanconi syndrome induced by ifosfamide without compromising its antitumor activity

      ONCOLOGY RESEARCH
    41. Bengel, FM; Schwaiger, M
      Nuclear medicine studies of the heart

      EUROPEAN RADIOLOGY
    42. HASINOFF BB; HELLMANN K; HERMAN EH; FERRANS VJ
      CHEMICAL, BIOLOGICAL AND CLINICAL ASPECTS OF DEXRAZOXANE AND OTHER BISDIOXOPIPERAZINES

      Current medicinal chemistry
    43. GREEN M
      ANTHRACYCLINE CARDIOTOXICITY, NO LONGER AN ISSUE

      Annals of oncology
    44. LOPEZ M; VICI P; DILAURO L; CONTI F; PAOLETTI G; FERRAIRONI A; SCIUTO R; GIANNARELLI D; MAINI CL
      RANDOMIZED PROSPECTIVE CLINICAL-TRIAL OF HIGH-DOSE EPIRUBICIN AND DEXRAZOXANE IN PATIENTS WITH ADVANCED BREAST-CANCER AND SOFT-TISSUE SARCOMAS

      Journal of clinical oncology
    45. EWER MS; JAFFE N; RIED H; ZIETZ HA; BENJAMIN RS
      DOXORUBICIN CARDIOTOXICITY IN CHILDREN - COMPARISON OF A CONSECUTIVE DIVIDED DAILY DOSE ADMINISTRATION SCHEDULE WITH SINGLE-DOSE (RAPID) INFUSION ADMINISTRATION

      Medical and pediatric oncology
    46. HERMAN EH; FERRANS V
      PRECLINICAL ANIMAL-MODELS OF CARDIAC PROTECTION FROM ANTHRACYCLINE-INDUCED CARDIOTOXICITY

      Seminars in oncology
    47. SYNOLD TW; TETEF ML; DOROSHOW JH
      ANTINEOPLASTIC ACTIVITY OF CONTINUOUS EXPOSURE TO DEXRAZOXANE - POTENTIAL NEW ROLE AS A NOVEL TOPOISOMERASE-II INHIBITOR

      Seminars in oncology
    48. ELIHU N; ANANDASBAPATHY S; FRISHMAN WH
      CHELATION-THERAPY IN CARDIOVASCULAR-DISEASE - ETHYLENEDIAMINETETRAACETIC ACID, DEFEROXAMINE, AND DEXRAZOXANE

      Journal of clinical pharmacology
    49. MORISHIMA I; MATSUI H; MUKAWA H; HAYASHI K; TOKI Y; OKUMURA K; ITO T; HAYAKAWA T
      MELATONIN, A PINEAL HORMONE WITH ANTIOXIDANT PROPERTY, PROTECTS AGAINST ADRIAMYCIN CARDIOMYOPATHY IN RATS

      Life sciences (1973)
    50. KAPELKO VI; KHATKEVICH AN; TSYPLENKOVA VG; BESKROVNOVA NN
      INITIAL ALTERATIONS OF MYOCARDIAL-FUNCTION AND ULTRASTRUCTURE CAUSED BY LOW-DOSES OF ADRIAMYCIN

      Kardiologia
    51. Vatutin, NT; Kalinkina, NV
      Cardiac damage by cytostatics

      KARDIOLOGIYA
    52. TORTI SV; AKIMOTO H; LIN K; BILLINGHAM ME; TORTI FM
      SELECTIVE-INHIBITION OF MUSCLE GENE-EXPRESSION BY OXIDATIVE STRESS INCARDIAC-CELLS

      Journal of Molecular and Cellular Cardiology
    53. WISEMAN LR; SPENCER CM
      DEXRAZOXANE - A REVIEW OF ITS USE AS A CARDIOPROTECTIVE AGENT IN PATIENTS RECEIVING ANTHRACYCLINE-BASED CHEMOTHERAPY

      Drugs
    54. SCHWARZ ER; POLLICK C; DOW J; PATTERSON M; BIRNBAUM Y; KLONER RA
      A SMALL ANIMAL-MODEL OF NONISCHEMIC CARDIOMYOPATHY AND ITS EVALUATIONBY TRANSTHORACIC ECHOCARDIOGRAPHY

      Cardiovascular Research
    55. ROSING H; VANGIJN R; HUININK WWT; BEIJNEN JH
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF THE CARDIOPROTECTIVE AGENT DEXRAZOXANE IN HUMAN PLASMA AND URINE

      Journal of liquid chromatography & related technologies
    56. SCHAADT B; KELBAEK H
      AGE AND LEFT-VENTRICULAR EJECTION FRACTION IDENTIFY PATIENTS WITH ADVANCED BREAST-CANCER AT HIGH-RISK FOR DEVELOPMENT OF EPIRUBICIN-INDUCEDHEART-FAILURE

      Journal of nuclear cardiology
    57. MAINI CL; SCIUTO R; FERRAIRONI A; VICI P; TOFANI A; FESTA A; CONTI F; LOPEZ M
      CLINICAL RELEVANCE OF RADIONUCLIDE ANGIOGRAPHY AND ANTIMYOSIN IMMUNOSCINTIGRAPHY FOR RISK ASSESSMENT IN EPIRUBICIN CARDIOTOXICITY

      Journal of nuclear cardiology
    58. HERMAN EH; FERRANS VJ
      ANIMAL-MODELS OF ANTHRACYCLINE CARDIOTOXICITY - BASIC MECHANISMS AND CARDIOPROTECTIVE ACTIVITY

      Progress in pediatric cardiology
    59. BOUCEK RJ
      MECHANISMS FOR ANTHRACYCLINE-INDUCED CARDIOMYOPATHY - CLINICAL AND LABORATORY CORRELATIONS

      Progress in pediatric cardiology
    60. EKSBORG S; BJORKHOLM M; HAST R; FAGERLUND E
      PLASMA PHARMACOKINETICS OF IDARUBICIN AND ITS 13-DIHYDRO METABOLITE -A COMPARISON OF BOLUS VERSUS 2 H INFUSION DURING A 3 DAY COURSE

      Anti-cancer drugs
    61. PROPPER D; MASER E
      CARBONYL REDUCTION OF DAUNORUBICIN IN RABBIT LIVER AND HEART

      Pharmacology & toxicology
    62. SINGAL PK; ILISKOVIC N; LI TM; KUMAR D
      ADRIAMYCIN CARDIOMYOPATHY - PATHOPHYSIOLOGY AND PREVENTION

      The FASEB journal
    63. HERMAN EH; ZHANG J; HASINOFF BB; CHADWICK DP; CLARK JR; FERRANS VJ
      COMPARISON OF THE PROTECTIVE EFFECTS AGAINST CHRONIC DOXORUBICIN CARDIOTOXICITY AND THE RATES OF IRON(III) DISPLACEMENT-REACTIONS OF ICRF-187 AND OTHER BISDIKETOPIPERAZINES

      Cancer chemotherapy and pharmacology
    64. CUSACK BJ; YOUNG SP; VESTAL RE; OLSON RD
      AGE-RELATED PHARMACOKINETICS OF DAUNORUBICIN AND DAUNORUBICINOL FOLLOWING INTRAVENOUS BOLUS DAUNORUBICIN ADMINISTRATION IN THE RAT

      Cancer chemotherapy and pharmacology
    65. WEIJL NI; CLETON FJ; OSANTO S
      FREE-RADICALS AND ANTIOXIDANTS IN CHEMOTHERAPY-INDUCED TOXICITY

      Cancer treatment reviews
    66. SUNG RYT; HUANG GY; SHING MK; OPPENHEIMER SJ; LI CK; LI CK; LAU J; YUEN MP
      ECHOCARDIOGRAPHIC EVALUATION OF CARDIAC-FUNCTION IN PEDIATRIC ONCOLOGY PATIENTS TREATED WITH OR WITHOUT ANTHRACYCLINE

      International journal of cardiology
    67. MATSUDA A; KIMURA M; ITOKAWA Y
      INFLUENCE OF SELENIUM DEFICIENCY ON THE ACUTE CARDIOTOXICITY OF ADRIAMYCIN IN RATS

      Biological trace element research
    68. PENG NJ; ADVANI R; KOPIWODA S; FISHER G; STRAUSS HW
      CLINICAL DECISION-MAKING BASED ON RADIONUCLIDE DETERMINED EJECTION FRACTION IN ONCOLOGY PATIENTS

      The Journal of nuclear medicine
    69. WITTRY MD; JUNI JE; ROYAL HD; HELLER GV; PORT SC
      PROCEDURE GUIDELINE FOR EQUILIBRIUM RADIONUCLIDE VENTRICULOGRAPHY

      The Journal of nuclear medicine
    70. FRISHMAN WH; YEE HCM; KEEFE D; DUTCHER J; SUNG HM; LIU LL; EINZIG AI
      CARDIOVASCULAR TOXICITY WITH CANCER-CHEMOTHERAPY

      Current problems in cancer
    71. DEGRAAF H; DOLSMA WV; WILLEMSE PHB; VANDERGRAAF WTA; SLEIJFER DT; DEVRIES EGE; MULDER NH
      CARDIOTOXICITY FROM INTENSIVE CHEMOTHERAPY COMBINED WITH RADIOTHERAPYIN BREAST-CANCER

      British Journal of Cancer
    72. JOHNSON D; PERRAULT H; FOURNIER A; LECLERC JM; BIGRAS JL; DAVIGNON A
      CARDIOVASCULAR-RESPONSES TO DYNAMIC SUBMAXIMAL EXERCISE IN CHILDREN PREVIOUSLY TREATED WITH ANTHRACYCLINE

      The American heart journal
    73. CUSACK BJ; MUSHLIN PS; JOHNSON CJ; VESTAL RE; OLSON RD
      AGING INCREASES THE CARDIOTOXICITY OF DAUNORUBICIN AND DAUNORUBICINOLIN THE RAT

      The journals of gerontology. Series A, Biological sciences and medical sciences
    74. JOHNSON GL; MOFFETT CB; GEIL JD; GREENWOOD MF; NOONAN JA
      LATE ECHOCARDIOGRAPHIC FINDINGS FOLLOWING CHILDHOOD CHEMOTHERAPY WITHNORMAL SERIAL CARDIAC MONITORING

      Journal of pediatric hematology/oncology
    75. JAIN D; ZARET BL
      MYOCARDITIS - A CLINICAL ENTITY THAT CAN BENEFIT FROM NONINVASIVE IMAGING

      Journal of nuclear cardiology
    76. BOVEN E; DEJONG J; KUIPER CM; BAST A; VANDERVIJGH WJF
      RELATIONSHIP BETWEEN THE TUMOR-TISSUE PHARMACOKINETICS AND THE ANTIPROLIFERATIVE EFFECTS OF ANTHRACYCLINES AND THEIR METABOLITES

      European journal of cancer
    77. PIHKALA J; SAARINEN UM; LUNDSTROM U; VIRTANEN K; VIRKOLA K; SIIMES MA; PESONEN E
      MYOCARDIAL-FUNCTION IN CHILDREN AND ADOLESCENTS AFTER THERAPY WITH ANTHRACYCLINES AND CHEST IRRADIATION

      European journal of cancer
    78. MIZUNO Y; HARA T; KAWAOTO H; UEDA K
      ATTENUATION OF CARDIOTOXICITY OF DAUNOMYCIN USING A COMPLEX WITH HEPARIN

      International journal of hematology
    79. NOWAK D; DRZEWOSKI J
      ANTHRACYCLINE-INDUCED OXIDATIVE STRESS - ITS ROLE IN THE DEVELOPMENT OF CARDIAC DAMAGE

      The Cancer journal
    80. LIPSHULTZ SE
      DEXRAZOXANE FOR PROTECTION AGAINST CARDIOTOXIC EFFECTS OF ANTHRACYCLINES IN CHILDREN

      Journal of clinical oncology
    81. COTTIN Y; TOUZERY C; COUDERT B; RICHEBOURG S; COHEN M; TOUBEAU M; LOUIS P; WOLF JE; BRUNOTTE F
      DIASTOLIC OR SYSTOLIC LEFT AND RIGHT-VENTRICULAR IMPAIRMENT AT MODERATE DOSES OF ANTHRACYCLINE - A 1-YEAR FOLLOW-UP-STUDY OF WOMEN

      European journal of nuclear medicine
    82. CARRIO I; ESTORCH M; LOPEZPOUSA A
      ASSESSING ANTHRACYCLINE CARDIOTOXICITY IN THE 1990S

      European journal of nuclear medicine
    83. DELLATORRE P; PODESTA A; PINCIROLI G; IATROPOULOS MJ; MAZUE G
      LONG-LASTING EFFECT OF DEXRAZOXANE AGAINST ANTHRACYCLINE CARDIOTOXICITY IN RATS

      Toxicologic pathology
    84. DAVTYAN TK; GYULKHANDANYAN AV; GAMBAROV SS; AVANESSIAN LA; ALEXANYAN YT
      THE EFFECTS OF ADRIAMYCIN AND ADRIAMYCIN COMPLEXES WITH TRANSITIONAL METALS ON CA2(-DEPENDENT K+ CHANNELS OF HUMAN ERYTHROCYTES())

      Biochimica et biophysica acta. Protein structure and molecular enzymology
    85. FRISHMAN WH; SUNG HM; YEE HCM; LIU LL; EINZIG AI; DUTCHER J; KEEFE D
      CARDIOVASCULAR TOXICITY WITH CANCER-CHEMOTHERAPY - INTRODUCTION

      Current problems in cardiology
    86. DORR RT
      CYTOPROTECTIVE AGENTS FOR ANTHRACYCLINES

      Seminars in oncology
    87. POUNA P; BONORONADELE S; GOUVERNEUR G; TARIOSSE L; BESSE P; ROBERT J
      DEVELOPMENT OF THE MODEL OF RAT ISOLATED-PERFUSED HEART FOR THE EVALUATION OF ANTHRACYCLINE CARDIOTOXICITY AND ITS CIRCUMVENTION

      British Journal of Pharmacology
    88. BULOCK FA; MOTT MG; OAKHILL A; MARTIN RP
      EARLY IDENTIFICATION OF ANTHRACYCLINE CARDIOMYOPATHY - POSSIBILITIES AND IMPLICATIONS

      Archives of Disease in Childhood
    89. MASSING JL; CAILLOT D; MOUHAT T; SCHLESSER P; SOLARY E
      EARLY DIAGNOSIS OF ANTHRACYCLINE CARDIOTO XICITY - VALUE OF RADIOISOTOPIC METHODS

      Archives des maladies du coeur et des vaisseaux
    90. HERSHKO C; PINSON A; LINK G
      PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY BY IRON CHELATION

      Acta haematologica
    91. LICHTMAN SM
      PHYSIOLOGICAL-ASPECTS OF AGING - IMPLICATIONS FOR THE TREATMENT OF CANCER

      Drugs & aging
    92. DHINGRA K; FRYE D; NEWMAN RA; WALTERS R; THERIAULT R; FRASCHINI G; SMITH T; BUZDAR A; HORTOBAGYI GN
      PHASE-II CLINICAL AND PHARMACOLOGICAL STUDY OF PIRARUBICIN IN COMBINATION WITH 5-FLUOROURACIL AND CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER

      Clinical cancer research
    93. NARULA J; SOUTHERN JF; DEC GW; PALACIOS IF; NEWELL JB; FALLON JT; STRAUSS HW; KHAW BA; YASUDA T
      ANTIMYOSIN UPTAKE AND MYOFIBRILLARLYSIS IN DILATED CARDIOMYOPATHY

      Journal of nuclear cardiology
    94. CARRIO I; BALLESTER M
      CLINICAL FUTURE OF ANTIMYOSIN IMAGING IN NONCORONARY HEART-DISEASE

      Journal of nuclear cardiology
    95. MAINI CL; PERRAIRONI A; SCIUTO R; VICI P; TOFANI A; CONTI F; LOPEZ M
      CARDIOTOXICITY OF HIGH-DOSE-RATE EPIRUBICIN EVALUATED BY ANGIOCARDIOSCINTIGRAPHY

      Oncology Reports
    96. MAZUE G; IATROPOULOS M; IMONDI A; CASTELLINO S; BRUGHERA M; PODESTA A; DELLATORRE P; MONETA D
      ANTHRACYCLINES - A REVIEW OF GENERAL AND SPECIAL TOXICITY STUDIES

      International journal of oncology
    97. OLMOS RAV; HUININK WWT; TENHOEVE RFA; VANTINTEREN H; BRUNING PF; VANVLIES B; HOEFNAGEL CA
      ASSESSMENT OF ANTHRACYCLINE-RELATED MYOCARDIAL ADRENERGIC DERANGEMENTBY [I-123] METAIODOBENZYLGUANIDINE SCINTIGRAPHY

      European journal of cancer
    98. PEIN F; VASSAL G; SAKIROGLU C; TOURNADE MF; LEMERLE J
      PEDIATRIC FEATURES OF ANTHRACYCLINES CARD IAC TOXICITY AND PRACTICAL IMPLICATIONS FOR PREVENTION

      Archives de pediatrie
    99. HOUSTON SH; SINNOTT JT
      MANAGEMENT OF THE TRANSPLANT RECIPIENT WITH PULMONARY INFECTION

      Infectious disease clinics of North America
    100. ANDERLINI P; BENJAMIN RS; WONG FC; KANTARJIAN HM; ANDREEFF M; KORNBLAU SM; OBRIEN S; MACKAY B; EWER MS; PIERCE SA; ESTEY EH
      IDARUBICIN CARDIOTOXICITY - A RETROSPECTIVE STUDY IN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASIA

      Journal of clinical oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 02:21:02